0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

[+] Author Affiliations

Section Editor: Robin L. Travers, MD


Arch Dermatol. 2009;145(6):631. doi:10.1001/archdermatol.2009.113.
Text Size: A A A
Published online

THIOGUANINE NUCLEOTIDES AND THIOPURINE METHYLTRANSFERASE IN IMMUNOBULLOUS DISEASES

Azathioprine has been used by dermatologists as a corticosteroid-sparing agent for 30 years, but its mechanism and pharmacokinetics remain unclear. Azathioprine is metabolized by the liver to 6-mercaptopurine, which in turn is converted to either active 6-thioguanine nucleotides (6-TGN) or the inactive 6-methylmercaptopurine. The current standard of care involves measurement of thiopurine methyltransferase activity prior to treatment to determine the level of this important enzyme that is involved in the hematopoietic toxic effects of azathioprine. In this prospective longitudinal study, el-Azhary et al determined optimal levels of 6-TGN for disease remission in patients with immunobullous disease, offering dermatologists a guide for monitoring patients receiving azathioprine.

See

TOPICAL FLUOROURACIL FOR ACTINIC KERATOSES AND PHOTOAGING

Fluorouracil is an antimetabolite chemotherapeutic agent that inhibits the synthesis of thymine, a critical building block of DNA. Topical fluorouracil has taken a place among the top tier of therapies for the treatment of actinic keratoses. A softening and smoothing of the skin's texture has been noted incidentally following such treatment. In this nonrandomized, open-label, 2-week study of treatment with fluorouracil cream, 5% Sachs et al demonstrate improvement in both actinic keratoses and photoaging that was associated with the molecular correlates of epidermal injury and the subsequent wound-healing response.

See

PRIMARY CUTANEOUS T-CELL LYMPHOMA LOCALIZED TO THE LOWER LEG

Cutaneous T-cell lymphoma (CTCL) is classified according to the World Health Organization and the European Organization for Research and Treatment of Cancer classification system for cutaneous lymphomas. This scheme recognizes 2 broad categories of CTCL: mycosis fungoides (MF)/Sézary syndrome and non-MF CTCLs. The latter group is much less common and is classified by histopathologic features and clinical behavior. In this case series, Poligone et al describe 3 patients with a CTCL variant localized to the legs, predominantly below the knee. The aggressive nature of these cases suggests that the lower leg site may be associated with either a compromised antitumor response or promotion of tumor progression.

See

PREGNANCY AND ESTROGEN RECEPTOR Β EXPRESSION IN A LARGE CONGENITAL NEVUS

Large congenital nevi carry a slightly elevated risk of melanoma. Pregnancy poses additional challenges for monitoring these lesions because the role of pregnancy in melanoma remains unclear. In this case report, Nading et al describe a young woman with a giant congenital nevus who developed lightening of her nevus and various satellite nevi during pregnancy followed by nevus darkening post partum. Immunohistochemical studies demonstrated decreased estrogen receptor β (ERβ) staining during pregnancy and increased staining following delivery. Because acquired melanocytic nevi demonstrate increased ERβ staining during pregnancy, the authors suggest that congenital nevi may be unique in their response to altered estrogen levels.

See

ASSOCIATION OF PSORIASIS WITH CORONARY ARTERY, CEREBROVASCULAR, AND PERIPHERAL VASCULAR DISEASES AND MORTALITY

Psoriasis is a common skin disorder with systemic inflammatory manifestations. Not only are cardiovascular disease risk factors more prevalent among patients with psoriasis, but psoriasis itself confers an independent risk for myocardial infarction. Because atherosclerosis is a systemic disease, it is reasonable to assume that other manifestations of atherosclerosis might also be increased among patients with psoriasis. In this observational study of patients with psoriasis, Prodanovich et al demonstrate a higher prevalence of not only ischemic heart disease but also cerebrovascular and peripheral vascular disease. Psoriasis was found to be an independent risk factor for mortality, suggesting that clinicians caring for patients with psoriasis may consider a lower threshold for atherosclerotic disease screening.

See

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

244 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs